Amifostine (CAS 20537-88-6): A Protective Agent in Cancer Therapy and Radiation Protection
Discover the critical role of Amifostine (CAS 20537-88-6) in mitigating the harsh side effects of cancer treatments, acting as a vital pharmaceutical intermediate and a key player in protecting healthy cells.
Get a Quote & SampleProduct Core Value
Amifostine
Amifostine, a significant pharmaceutical intermediate, is renowned for its cytoprotective properties, shielding healthy tissues from the damaging effects of chemotherapy and radiation. As a reliable supplier in China, we provide high-quality Amifostine to support advanced medical research and therapeutic applications.
- Amifostine cancer therapy side effects are significantly reduced, offering patients a better quality of life during treatment.
- This potent compound functions as a key pharmaceutical intermediate, enabling the synthesis of vital therapeutic agents.
- As a protective agent, Amifostine aids in Amifostine radiation protection by neutralizing harmful free radicals.
- Explore opportunities to buy Amifostine CAS 20537-88-6 from a trusted manufacturer in China.
Advantages Offered
Enhanced Patient Comfort
The use of Amifostine as a cytoprotective agent greatly improves patient tolerance to cancer treatments, directly addressing Amifostine cancer therapy side effects.
Cellular Protection Mechanism
Leveraging its ability to scavenge free radicals, Amifostine provides crucial Amifostine radiation protection, preserving the integrity of healthy cells.
Critical Pharmaceutical Intermediate
As a vital pharmaceutical intermediate, Amifostine is instrumental in the development of new and improved cancer therapies.
Key Applications
Cancer Therapy Support
Amifostine is integral to cancer treatment protocols, mitigating the adverse effects associated with various therapies, a key area for understanding Amifostine cancer therapy side effects.
Radiation Protection
Its role in Amifostine radiation protection makes it invaluable for patients undergoing radiotherapy, helping to preserve normal tissue function.
Chemotherapy Adjunct
As a cytoprotective agent, it is often administered alongside chemotherapy to prevent organ damage, highlighting its importance as a pharmaceutical intermediate.
Drug Development
Researchers actively seek to buy Amifostine CAS 20537-88-6 for its potential in developing new protective strategies against cellular damage.